2025.12.10 | Structural Instability: Why Your Generic Drugs Are Now At Risk

Policy makers and businesses are navigating 2025 blind as critical economic data vanishes and domestic tensions rise. We analyze the triple threat of the delayed GDP report, rising political confrontation, and the massive pharmaceutical supply chain shift caused by the Biosecure Act. Learn the structural change cementing the end of the cheap labor era and why persistent costs for labor and protein will remain high through 2026. This episode provides specific defensive planning steps—from securing critical generic drugs to enhancing obscurity—to help you find reliable ground truth when the national dashboard goes dark.